These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3924349)

  • 21. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separation of the motor consequences from other actions of unilateral 6-hydroxydopamine lesions in the nigrostriatal neurones of rat brain.
    Hamilton MH; Garcia-Munoz M; Arbuthnott GW
    Brain Res; 1985 Dec; 348(2):220-8. PubMed ID: 3907747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos.
    Robertson GS; Vincent SR; Fibiger HC
    Brain Res; 1990 Jul; 523(2):288-90. PubMed ID: 2144781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic neurons: simultaneous measurements of dopamine release and single-unit activity during stimulation of the medial forebrain bundle.
    Kuhr WG; Wightman RM; Rebec GV
    Brain Res; 1987 Aug; 418(1):122-8. PubMed ID: 3499205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats.
    Wictorin K; Brundin P; Sauer H; Lindvall O; Björklund A
    J Comp Neurol; 1992 Sep; 323(4):475-94. PubMed ID: 1358925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons.
    Hefti F; Hartikka J; Schlumpf M
    Brain Res; 1985 Dec; 348(2):283-8. PubMed ID: 4075086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
    Hefti F; Melamed E; Wurtman RJ
    Brain Res; 1980 Aug; 195(1):123-37. PubMed ID: 6105003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term effects of dopamine-depleting brain lesions on spontaneous activity of striatal neurons: relation to local dopamine concentration and behavior.
    Orr WB; Gardiner TW; Stricker EM; Zigmond MJ; Berger TW
    Brain Res; 1986 Jun; 376(1):20-8. PubMed ID: 3087583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for the dopaminergic nigrostriatal bundle in the pathogenesis of altered brain glucose consumption after lateral hypothalamic lesions. Evidence using the 14C-labeled deoxyglucose technique.
    Schwartz WJ
    Brain Res; 1978 Dec; 158(1):129-47. PubMed ID: 21348356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
    Creese I; Iversen SD
    Psychopharmacol Bull; 1975 Oct; 11(4):12-3. PubMed ID: 1197588
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 38. Stimulation of the subthalamic nucleus enhances the release of dopamine in the rat substantia nigra.
    Mintz I; Hammond C; Guibert B; Leviel V
    Brain Res; 1986 Jun; 376(2):406-8. PubMed ID: 3730844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway.
    Dunnett SB; Björklund A; Stenevi U; Iversen SD
    Brain Res; 1981 Dec; 229(1):209-17. PubMed ID: 6796195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective lesions of central catecholamine pathways: application in functional studies.
    Ungerstedt U
    Neurosci Res (N Y); 1973; 5(0):73-96. PubMed ID: 4600813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.